ZoeNCure Therapeutics Private Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ZoeNCure Therapeutics Private Limited - overview
Established
2024
Location
Faridabad, Haryana, India
Primary Industry
Biotechnology
About
Based in India, ZoeNCure Therapeutics Private Limited, operates as a developer of ADC and cell therapy products for cancer treatment. Based in Faridabad, India and founded in 2024, ZoeNCure Therapeutics Private Limited specializes in the development of antibody-drug conjugates (ADCs) and cell therapies. The company raised INR 25 mn in pre-seed funding from individual investors, marking its initial financial backing. This funding supports their focus on innovative cancer treatments, particularly in the oncology sector.
ZoeNCure Therapeutics specializes in the innovative development of antibody-drug conjugates (ADCs) and cell therapies aimed at addressing challenging cancers with significant unmet medical needs. Their core product offerings center around the engineering of next-generation ADCs designed to overcome the limitations of earlier therapeutic approaches, such as efficacy and safety concerns. These therapies are based on validated tumor biology and tailored targeting strategies, validating their therapeutic constructs by focusing on biological relevance, clinical evidence, and prevalence among Indian patients. The company operates primarily in the oncology sector, aiming to deliver its advanced therapeutics to clinicians and healthcare providers, thereby serving cancer patients in India and potentially extending global reach through strategic partnerships.
As ZoeNCure Therapeutics progresses with FDA-regulated clinical development, their therapies are directed at treating specific high-potential cancer indications, thereby catering to a patient base that truly requires innovative treatment options. The revenue model for ZoeNCure Therapeutics encompasses various streams attributed to their development of ADCs and cell therapies, primarily operating through partnerships with healthcare entities and research institutions. Transactions may include collaborative agreements or joint ventures to facilitate clinical trials and commercialization of their therapeutics within oncology. The company may engage in a business-to-business (B2B) format by providing their ADC and cell therapy products to hospitals and specialized clinics, ensuring direct access to end users, which are the patients receiving these therapies.
Specific pricing structures for each pharmaceutical product often reflect the developmental costs involved, necessitating careful pricing strategies aligned with market dynamics and therapeutic value. The company's commitment to an India-first development approach includes offering accessible treatment options at a commercially sustainable cost, supporting healthcare systems while pursuing revenue growth through these strategic business engagements. The company plans to utilize the INR 25 mn raised in pre-seed funding to advance its research and development efforts in ADCs and cell therapies. Current initiatives include expanding their clinical trials and enhancing their product offerings to address specific cancer indications, thereby improving treatment accessibility for patients in India.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.zoencure.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
ZoeNCure Therapeutics Private Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | ZoeNCure Therapeutics Private Limited | - | ||||||||
| Unspecified Round | Completed | ZoeNCure Therapeutics Private Limited | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.